Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Stents/adverse effects"'
Autor:
Coughlan, J J, Räber, Lorenz, Brugaletta, Salvatore, Kufner, Sebastian, Maeng, Michael, Jensen, Lisette Okkels, Ortega-Paz, Luis, Bär, Sarah, Laugwitz, Karl-Ludwig, Madsen, Morten, Heg, Dik, Aytekin, Alp, Windecker, Stephan, Olesen, Kevin Kris Warnakula, Sabaté, Manel, Kastrati, Adnan, Cassese, Salvatore
Publikováno v:
Coughlan, J J, Räber, L, Brugaletta, S, Kufner, S, Maeng, M, Jensen, L O, Ortega-Paz, L, Bär, S, Laugwitz, K-L, Madsen, M, Heg, D, Aytekin, A, Windecker, S, Olesen, K K W, Sabaté, M, Kastrati, A & Cassese, S 2023, ' Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents : Insights From the DECADE Cooperation ', Circulation, vol. 147, no. 7, pp. 575-585 . https://doi.org/10.1161/CIRCULATIONAHA.122.062049
Background: Although some studies have investigated sex-related outcomes up to 5 years after percutaneous coronary intervention (PCI), analyses at longer follow-up (ie, to 10 years) in large cohorts treated exclusively with drug-eluting stent (DES) p
Autor:
Julia Ellert-Gregersen, Lisette Jensen Jensen, Lars Jakobsen, Phillip Michael Freeman, Ashkan Eftekhari, Michael Maeng, Bent Raungaard, Thomas Engstroem, Johnny Kahlert, Henrik Hansen Hansen, Evald Høj Christiansen
Publikováno v:
Ellert-Gregersen, J, Jensen, L O, Jakobsen, L, Freeman, P M, Eftekhari, A, Maeng, M, Raungaard, B, Engstroem, T, Kahlert, J, Hansen, H S & Christiansen, E H 2022, ' Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents : two-year outcomes of the randomised SORT OUT IX trial ', EuroIntervention, vol. 18, no. 2, pp. e124-e131 . https://doi.org/10.4244/EIJ-D-21-00874
EuroIntervention
EuroIntervention
BACKGROUND: For patients with high bleeding risk, the BioFreedom stent is safer and more effective than a bare metal stent. However, at the one-year follow-up of the SORT OUT IX trial, the BioFreedom stent did not meet the criteria for non-inferiorit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8162816a489c072dd7fea9ad3789a72
https://pure.au.dk/portal/da/publications/polymerfree-biolimuscoated-stents-versus-ultrathinstrut-biodegradable-polymer-sirolimuseluting-stents(07ecf6dc-431f-42d3-8eb5-c856a0781da8).html
https://pure.au.dk/portal/da/publications/polymerfree-biolimuscoated-stents-versus-ultrathinstrut-biodegradable-polymer-sirolimuseluting-stents(07ecf6dc-431f-42d3-8eb5-c856a0781da8).html
Autor:
Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen
Publikováno v:
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2023, ' Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 101, no. 1, pp. 13-21 . https://doi.org/10.1002/ccd.30480
OBJECTIVES: To compare the efficacy and safety of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (O-SES) in patients with and without acute coronary syndrome (ACS) included in the SOR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a328322cab723340935d6d4ac01587
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
Publikováno v:
Progrès en Urologie
Progrès en Urologie, Elsevier Masson, 2020, 30 (5), pp.261-266. ⟨10.1016/j.purol.2020.02.004⟩
Progrès en Urologie, Elsevier Masson, 2020, 30 (5), pp.261-266. ⟨10.1016/j.purol.2020.02.004⟩
Urological recommendations never focused on prevention and treatment of urinary tract infections related to endo-ureteral material.Methods: We conducted an evaluation of French professional practices in May 2019 in the aim of highlighting the importa
Autor:
Markus, H.S., Michel, P.
Publikováno v:
International journal of stroke, vol. 17, no. 7, pp. 723-732
One-fifth of strokes occur in the territory of the posterior circulation, but their management, particularly acute reperfusion therapy and neurointervention procedures for secondary prevention, has received much less attention than similar interventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::f5d80483a8854f41755f38347e69d40d
https://serval.unil.ch/notice/serval:BIB_107985A69BF1
https://serval.unil.ch/notice/serval:BIB_107985A69BF1
Autor:
Otmar Pfister, Matthias Pfisterer, Gregor Fahrni, Marco E. G. V. Cattaneo, David Conen, Michael Coslovsky, Thomas Engstrøm, Sven Möbius-Winkler, Raphael Twerenbold, Søren Galatius, Ahmed Farah, Franz R. Eberli, Gerhard Schuler, Christian Mueller, Christoph Kaiser, Peter Rickenbacher, Raban Jeger, Norman Mangner
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Fahrni, G, Farah, A, Engstrøm, T, Galatius, S, Eberli, F, Rickenbacher, P, Conen, D, Mueller, C, Pfister, O, Twerenbold, R, Coslovsky, M, Cattaneo, M, Kaiser, C, Mangner, N, Schuler, G, Pfisterer, M, Möbius-Winkler, S, Jeger, R V & BASKET-SAVAGE-Investigators* 2020, ' Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts : Randomized Controlled Trial ', Journal of the American Heart Association, vol. 9, no. 20, e017434 . https://doi.org/10.1161/JAHA.120.017434
Fahrni, G, Farah, A, Engstrøm, T, Galatius, S, Eberli, F, Rickenbacher, P, Conen, D, Mueller, C, Pfister, O, Twerenbold, R, Coslovsky, M, Cattaneo, M, Kaiser, C, Mangner, N, Schuler, G, Pfisterer, M, Möbius-Winkler, S, Jeger, R V & BASKET-SAVAGE-Investigators* 2020, ' Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts : Randomized Controlled Trial ', Journal of the American Heart Association, vol. 9, no. 20, e017434 . https://doi.org/10.1161/JAHA.120.017434
Background Efficacy data on drug‐eluting stents (DES) versus bare‐metal stents (BMS) in saphenous vein grafts are controversial. We aimed to compare DES with BMS among patients undergoing saphenous vein grafts intervention regarding long‐term o
Publikováno v:
Progrès en Urologie
Progrès en Urologie, Elsevier Masson, 2020, 30 (5), pp.261-266. ⟨10.1016/j.purol.2020.02.004⟩
Progrès en Urologie, Elsevier Masson, 2020, 30 (5), pp.261-266. ⟨10.1016/j.purol.2020.02.004⟩
International audience; Urological recommendations never focused on prevention and treatment of urinary tract infections related to endo-ureteral material.Methods: We conducted an evaluation of French professional practices in May 2019 in the aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4670c90bbb01c412c3bb895f90d97601
https://hal.umontpellier.fr/hal-03349297
https://hal.umontpellier.fr/hal-03349297
Publikováno v:
Journal of Glaucoma, Vol. 28, No 8 (2019) pp. 676-684
Precis: This study confirms the safety and efficacy of XEN gel stents in the management of pseudoexfoliative glaucoma 2 years after implantation, with success rates similar to primary open-angle glaucoma regardless of the definition of success. Purpo
Publikováno v:
Nepalese Journal of Ophthalmology, Vol. 10, No 20 (2018) pp. 184-187
DOI: https://doi.org/10.3126/nepjoph.v10i2.23030 Introduction: The iStent inject® (Glaukos Corporation, CA, USA) is a relatively new device designed to be implanted ab-interno through the trabecular meshwork. This is, to the best of our knowledge, t
Autor:
Sara J. Baart, Sander Ten Raa, Nelson Oliveira, Frederico Bastos Gonçalves, Sanne E. Hoeks, José Oliveira-Pinto, Hence J.M. Verhagen, Marie Josee Van Rijn
Publikováno v:
European Journal of Vascular and Endovascular Surgery, 62(1), 26-35. W.B. Saunders
Objective: Aortic neck dilatation (AND) occurs after endovascular aneurysm repair (EVAR) with self expanding stent grafts (SESs). Whether it continues, ultimately exceeding the endograft diameter leading to abdominal aortic aneurysm (AAA) rupture, re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c870e5222d8a95c901c3eb3790a29a
https://hdl.handle.net/10400.17/4119
https://hdl.handle.net/10400.17/4119